Loading...

NYXH

Nyxoah SA · NASDAQ

Performance

-2.29%

1W

-18.12%

1M

-48.4%

3M

+82.87%

6M

+84.05%

YTD

+3.7%

1Y

Profile

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Technical Analysis of NYXH 2024-05-31

Overview:

In analyzing the technical indicators for NYXH stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible future stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valu...

See more ...

Recent News & Updates